Article

Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox…

Journal of Parasitology Research · 2009 · Annamaria Buschini, author Lisa Ferrarini, author Susanna Franzoni, author Serena Galati, author Mirca Lazzaretti, author Francesca Mussi, author Cristina Northfleet de Albuquerque, author Tânia Maria Araújo Domingues Zucchi, author Paola Poli, author José F. Silveira, Academic Editor

Key facts

Title Genotoxicity Revaluation of Three Commercial Nitroheterocyclic Drugs: Nifurtimox, Benznidazole, and Metronidazole
First author Annamaria Buschini, author Lisa Ferrarini, author Susanna Franzoni, author Serena Galati, author Mirca Lazzaretti, author Francesca Mussi, author Cristina Northfleet de Albuquerque, author Tânia Maria Araújo Domingues Zucchi, author Paola Poli, author José F. Silveira, Academic Editor
Journal Journal of Parasitology Research
Published Apr 24, 2009
DOI 10.1155/2009/463575
Devices mentioned K040782, K842399, K981990
Product codes mentioned EFB, FPB, JAK

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature